Literature DB >> 21821083

Conceptual framework for behavioral and social science in HIV vaccine clinical research.

Chuen-Yen Lau1, Edith M Swann, Sagri Singh, Zuhayr Kafaar, Helen I Meissner, James P Stansbury.   

Abstract

HIV vaccine clinical research occurs within a context where biomedical science and social issues are interlinked. Previous HIV vaccine research has considered behavioral and social issues, but often treated them as independent of clinical research processes. Systematic attention to the intersection of behavioral and social issues within a defined clinical research framework is needed to address gaps, such as those related to participation in trials, completion of trials, and the overall research experience. Rigorous attention to these issues at project inception can inform trial design and conduct by matching research approaches to the context in which trials are to be conducted. Conducting behavioral and social sciences research concurrent with vaccine clinical research is important because it can help identify potential barriers to trial implementation, as well as ultimate acceptance and dissemination of trial results. We therefore propose a conceptual framework for behavioral and social science in HIV vaccine clinical research and use examples from the behavioral and social science literature to demonstrate how the model can facilitate identification of significant areas meriting additional exploration. Standardized use of the conceptual framework could improve HIV vaccine clinical research efficiency and relevance. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821083      PMCID: PMC3190058          DOI: 10.1016/j.vaccine.2011.07.108

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  67 in total

1.  Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-28       Impact factor: 3.295

2.  Health beliefs and intention to get immunized for HIV.

Authors:  G D Zimet; A Liau; V D Fortenberry
Journal:  J Adolesc Health       Date:  1997-05       Impact factor: 5.012

Review 3.  Structural interventions for HIV prevention in the United States.

Authors:  Adaora A Adimora; Judith D Auerbach
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

4.  Antiretroviral therapy: a promising HIV prevention strategy?

Authors:  Wafaa M El-Sadr; Megan Affrunti; Theresa Gamble; Allison Zerbe
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.

Authors:  R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

6.  A pilot study of the quality of informed consent materials for Aboriginal participants in clinical trials.

Authors:  F M Russell; J R Carapetis; H Liddle; T Edwards; T A Ruff; J Devitt
Journal:  J Med Ethics       Date:  2005-08       Impact factor: 2.903

7.  In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study.

Authors:  Paula M Frew; Wendy Macias; Kayshin Chan; Ashley C Harding
Journal:  J Health Mass Commun       Date:  2009

8.  Correlates of intention to use condoms among Sub-Saharan African youth: the applicability of the theory of planned behaviour.

Authors:  Herman Schaalma; Leif Edvard Aarø; Alan J Flisher; Catherine Mathews; Sylvia Kaaya; Hans Onya; Anders Ragnarson; Knut-Inge Klepp
Journal:  Scand J Public Health       Date:  2009-06       Impact factor: 3.021

Review 9.  Behavioural strategies to reduce HIV transmission: how to make them work better.

Authors:  Thomas J Coates; Linda Richter; Carlos Caceres
Journal:  Lancet       Date:  2008-08-05       Impact factor: 79.321

10.  Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial.

Authors:  Rachel Jewkes; M Nduna; J Levin; N Jama; K Dunkle; A Puren; N Duvvury
Journal:  BMJ       Date:  2008-08-07
View more
  9 in total

1.  Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis.

Authors:  A M Young; R J DiClemente; D S Halgin; C E Sterk; J R Havens
Journal:  AIDS Behav       Date:  2014-09

2.  Moving the bar to the right place: positioning interventions in HIV prevention.

Authors:  Beryl A Koblin; Gordon Mansergh; Margaret Chesney; Thomas Coates
Journal:  AIDS Behav       Date:  2014-04

3.  Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions.

Authors:  Beryl A Koblin; Michele Andrasik; Judy Austin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

Review 4.  Lessons learned from HIV vaccine clinical efficacy trials.

Authors:  Tracey A Day; James G Kublin
Journal:  Curr HIV Res       Date:  2013-09       Impact factor: 1.581

5.  Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania.

Authors:  Edith A M Tarimo; Joel Ambikile; Patricia Munseri; Muhammad Bakari
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

6.  Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.

Authors:  Igor P U Capitine; Ivalda B Macicame; Artur M Uanela; Nilesh B Bhatt; Adam Yates; Mark Milazzo; Chiaka Nwoga; Trevor A Crowell; Nelson L Michael; Merlin L Robb; Ilesh V Jani; Arne Kroidl; Christina S Polyak; Caroline De Schacht
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

7.  Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/II HIV vaccine trials.

Authors:  Theodora Mbunda; Muhammad Bakari; Edith A M Tarimo; Eric Sandstrom; Asli Kulane
Journal:  Glob Health Action       Date:  2014-02-25       Impact factor: 2.640

8.  Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.

Authors:  Dan Allman; Melissa Hope Ditmore; Karyn Kaplan
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

Review 9.  Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.

Authors:  Karine Dubé; Judith D Auerbach; Michael J Stirratt; Paul Gaist
Journal:  J Int AIDS Soc       Date:  2019-10       Impact factor: 5.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.